A detailed history of New Edge Advisors, LLC transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 55,675 shares of ASRT stock, worth $55,118. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,675
Previous 55,675 -0.0%
Holding current value
$55,118
Previous $59,000 10.17%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$1.02 - $2.57 $20,400 - $51,400
20,000 Added 56.06%
55,675 $59,000
Q3 2023

Nov 14, 2023

BUY
$2.52 - $5.69 $27,392 - $61,850
10,870 Added 43.82%
35,675 $91,000
Q2 2023

Aug 14, 2023

SELL
$5.0 - $7.66 $17,295 - $26,495
-3,459 Reduced 12.24%
24,805 $134,000
Q1 2023

May 12, 2023

BUY
$3.54 - $6.66 $67,695 - $127,359
19,123 Added 209.2%
28,264 $180,000
Q4 2022

Feb 14, 2023

BUY
$2.48 - $4.3 $22,669 - $39,306
9,141 New
9,141 $39,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $47.7M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.